Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage i non-small-cell lung cancer

Clinical Lung Cancer

Volumn 15, Issue 2, 2014, Pages

  Kanemoto, Ayae ^a   Okumura, Toshiyuki ^a   Ishikawa, Hitoshi ^a   Mizumoto, Masashi ^a   Oshiro, Yoshiko ^a   Kurishima, Koichi ^b   Homma, Shinsuke ^b   Hashimoto, Takayuki ^a   Ohkawa, Ayako ^a   Numajiri, Haruko ^a   Ohno, Toshiki ^a   Moritake, Takashi ^a   Tsuboi, Koji ^a   Sakae, Takeji ^a   Sakurai, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Outcome; Prognostic factor for tumor control; Proton beam therapy; Radiation dose; Stage I lung cancer

Indexed keywords

ADENOCARCINOMA; AGED; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW UP; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; PROTON THERAPY; RADIATION DOSE; RETROSPECTIVE STUDY; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTON THERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 84894033906     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.11.002     Document Type: Article

References (31)

1. K. Stephans Stereotactic body radiotherapy for stage I non-small cell lung cancer Cleve Clin J Med 79 2012 eS26 eS31
2. M. Hata, K. Tokuuye, and K. Kagei et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study Int J Radiat Oncol Biol Phys 68 2007 786 793
3. F.J. Lagerwaard, N.E. Verstegen, and C.J. Haasbeek et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 83 2012 348 353
4. K. Nihei, T. Ogino, and S. Ishikura et al. High-dose proton beam therapy for Stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 107 111
5. U. Ricardi, A.R. Filippi, and A. Guarneri et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial Lung Cancer 68 2010 72 77
6. S. Senthi, F.J. Lagerwaard, and C.J. Haasbeek et al. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis Lancet Oncol 13 2012 802 809
7. M. Uematsu, A. Shioda, and A. Suda et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience Int J Radiat Oncol Biol Phys 51 2001 666 670
8. D.A. Bush, J.D. Slater, and B.B. Shin et al. Hypofractionated proton beam radiotherapy for stage I lung cancer Chest 126 2004 1198 1203
9. L. Widesott, M. Amichetti, and M. Schwarz Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review Radiother Oncol 86 2008 154 164
10. A. Takeda, E. Kunieda, and N. Sanuki et al. Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer Lung Cancer 77 2012 77 82
11. M. Taremi, A. Hope, and M. Dahele et al. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients Int J Radiat Oncol Biol Phys 82 2012 967 973
12. A.V. Louie, G. Rodrigues, and M. Hannouf et al. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis Int J Radiat Oncol Biol Phys 81 2011 964 973
13. H. Onishi, H. Shirato, and Y. Nagata et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81 2011 1352 1358
14. J.Y. Chang, P.A. Balter, and L. Dong et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
15. C.J. Haasbeek, F.J. Lagerwaard, and B.J. Slotman et al. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer J Thorac Oncol 6 2011 2036 2043
16. H. Nakayama, S. Sugahara, and M. Tokita et al. Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba Int J Radiat Oncol Biol Phys 78 2010 467 471
17. H. Paganetti, A. Niemierko, and M. Ancukiewicz et al. Relative biological effectiveness (RBE) values for proton beam therapy Int J Radiat Oncol Biol Phys 53 2002 407 421
18. Y. Tsunashima, T. Sakae, and Y. Shioyama et al. Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy Int J Radiat Oncol Biol Phys 60 2004 951 958
19. N.E. Dunlap, W. Yang, and A. McIntosh et al. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 84 2012 1071 1077
20. Y. Shioyama, K. Tokuuye, and T. Okumura et al. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 56 2003 7 13
21. F.J. Lagerwaard, C.J. Haasbeek, and E.F. Smit et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
22. T. Xia, H. Li, and Q. Sun et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer Int J Radiat Oncol Biol Phys 66 2006 117 125
23. S.Y. Song, W. Choi, and S.S. Shin et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus Lung Cancer 66 2009 89 93
24. R. Timmerman, R. McGarry, and C. Yiannoutsos et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
25. H. Onishi, T. Araki, and H. Shirato et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631
26. N.E. Dunlap, J.M. Larner, and P.W. Read et al. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) J Thorac Cardiovasc Surg 140 2010 583 589
27. D.A. Bush, G. Cheek, and S. Zaheer et al. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at loma linda university medical center Int J Radiat Oncol Biol Phys 86 2013 964 968
28. J.P. Grutters, A.G. Kessels, and M. Pijls-Johannesma et al. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis Radiother Oncol 95 2010 32 40
29. N. Kadoya, Y. Obata, and T. Kato et al. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 79 2011 1225 1231
30. S.P. Register, X. Zhang, and R. Mohan et al. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 80 2011 1015 1022
31. J. Seco, H.R. Panahandeh, and K. Westover et al. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty Int J Radiat Oncol Biol Phys 83 2012 354 361